Veritas Pharma Signs Letter of Intent with 3 Carbon Extractions Inc.
08 mars 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the signing of a...
Veritas Pharma Provides Corporate Update on Q1 2018
21 févr. 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an official corporate...
Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1
20 févr. 2018 03h10 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the Company and its...
Veritas’ Research Arm Cannevert Signs Clinical Research Agreement for Human Studies to Assess its Lead Cannabis Strain for Pain
10 janv. 2018 17h02 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that its research arm,...
Veritas Pharma Provides Comment on U.S. Attorney General Jeff Sessions Memo
09 janv. 2018 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) and (Frankfurt:2VP), (“Veritas” or the “Company”) provides the following statement to the...
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders
04 janv. 2018 17h24 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its...
Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board
29 nov. 2017 16h30 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces the appointment of Mr. Robert “Rob”...
US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
28 nov. 2017 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK
22 nov. 2017 16h15 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that the scientists of its research...
Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski
14 nov. 2017 16h15 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT); (OTC:VRTHF); and (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has initiated a cancer...